Daniel Hart - Avid Bioservices Chief Officer
| CDMODelisted Stock | USD 12.49 0.00 0.00% |
Executive
Mr. Daniel R. Hart is Chief Financial Officer of the Company, effective August 1, 2018. He has served as Chief Financial Officer since August 1, 2018 and has over 20 years of finance and accounting experience. Mr. Hart is responsible for overseeing and managing all of our accounting and finance functions. Prior to joining us, Mr. Hart served as Chief Financial Officer of ENO Holdings, Inc., a family of companies focused on the residential real estate market with offerings spanning brokerage, franchisor, property management, title and escrow services. While with ENO Holdings, he helped optimize the groups accounting and finance department with a focus on establishing repeatable processes in the areas of financial statements, operating plans, cash forecasts and organization budgets. Prior to that position, Mr. Hart served as Senior Vice President, Chief Financial Officer and Assistant Secretary at SMA, a 100 million private equity owned management consulting firm that was previously a Nasdaqlisted company. During his time at SMA, which included several financial leadership positions of increasing responsibility, he was responsible for overseeing financial stewardship and played a central role in various financial transactions and corporate acquisitions since 2018.
| Age | 52 |
| Tenure | 7 years |
| Phone | 714 508 6100 |
| Web | https://www.avidbio.com |
Daniel Hart Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Hart against Avid Bioservices stock is an integral part of due diligence when investing in Avid Bioservices. Daniel Hart insider activity provides valuable insight into whether Avid Bioservices is net buyers or sellers over its current business cycle. Note, Avid Bioservices insiders must abide by specific rules, including filing SEC forms every time they buy or sell Avid Bioservices'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Hart over six months ago Acquisition by Daniel Hart of 2120 shares of Avid Bioservices subject to Rule 16b-3 |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of (0.0305) % which means that it has lost $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1584) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities.Avid Bioservices currently holds 207.83 M in liabilities with Debt to Equity (D/E) ratio of 1.02, which is about average as compared to similar companies. Avid Bioservices has a current ratio of 1.89, which is within standard range for the sector. Note, when we think about Avid Bioservices' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ling Zhou | Adagene | N/A | |
| DO Sr | Larimar Therapeutics | 63 | |
| Jolanda Howe | Mirum Pharmaceuticals | N/A | |
| John Berman | Larimar Therapeutics | N/A | |
| Gayathri Diwakar | Crinetics Pharmaceuticals | N/A | |
| Ashish MBA | Dyne Therapeutics | N/A | |
| Gloria Cosgrove | Lyra Therapeutics | N/A | |
| Amy Reilly | Dyne Therapeutics | 51 | |
| Richard MD | Lyra Therapeutics | 61 | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Stuart Naylor | MeiraGTx Holdings PLC | 62 | |
| Douglas Snyder | Ideaya Biosciences | 61 | |
| Nicole Sweeny | Kalvista Pharmaceuticals | 49 | |
| Cindy Berejikian | Mineralys Therapeutics, Common | N/A | |
| Debra Feldman | Dyne Therapeutics | 54 | |
| Edward Feener | Kalvista Pharmaceuticals | 64 | |
| Jennifer Johansson | Larimar Therapeutics | N/A | |
| John Bishop | Lyra Therapeutics | 62 | |
| James MD | AnaptysBio | 62 | |
| Sarah Foster | Mineralys Therapeutics, Common | N/A | |
| Yan MBA | Adagene | 50 | |
Management Performance
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, Chief Officer | ||
| Mark JD, General VP | ||
| Oksana Lukash, Vice People | ||
| Prof Brekken, Medical Advisor | ||
| Harold MD, Medical Advisor | ||
| Prof Schroit, Medical Advisor | ||
| Matthew Kwietniak, Chief Officer | ||
| Richard Richieri, Chief Officer | ||
| Tracy Kinjerski, VP Operations |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.16 | ||||
| Return On Asset | -0.0305 | ||||
| Profit Margin | (1.01) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 971.01 M | ||||
| Shares Outstanding | 63.96 M | ||||
| Shares Owned By Insiders | 1.13 % | ||||
| Shares Owned By Institutions | 98.87 % | ||||
| Number Of Shares Shorted | 11.62 M | ||||
| Price To Earning | 10.76 X |
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.Moving against Avid Stock
| 0.56 | MBRX | Moleculin Biotech Buyout Trend | PairCorr |
| 0.46 | DNLI | Denali Therapeutics | PairCorr |
| 0.44 | MBIO | Mustang Bio | PairCorr |
| 0.4 | VANI | Vivani Medical | PairCorr |
| 0.33 | MGNX | MacroGenics Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |